|4Apr 26, 5:18 PM ET

Accelmed Partners II L.P. 4

4 · NeuroPace Inc · Filed Apr 26, 2021

Insider Transaction Report

Form 4
Period: 2021-04-26
Transactions
  • Conversion

    Common Stock

    2021-04-26+3,454,4224,042,657 total
  • Conversion

    Series B' Preferred Stock

    2021-04-26+3,454,4223,454,422 total
    Exercise: $0.00Common Stock (3,454,422 underlying)
Footnotes (2)
  • [F1]Shares are held by Accelmed Partners II LP. Accelmed Partners II, LLC ("Accelmed LLC") is the general partner of Accelmed Partners II GP, L.P., which is the general partner of Accelmed Partners II LP. Uri Geiger is the managing partner of Accelmed LLC and has sole voting and dispositive power with respect to the shares held by Accelmed Partners II LP. Mr. Norton, a member of our board of directors, is a General Partner at Accelmed LLC. The address of each of Accelmed LLC, Accelmed Partners II GP, LP, Accelmed Partners II LP and Mr. Norton is Ugland House, South Church Street, PO Box 309, Grand Cayman KY1-1104, Cayman Islands.
  • [F2]Each share of Preferred Stock automatically converted on a 1-for-1 basis into Common Stock upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Stock has no expiration date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION